Neuromodulation for neurodegenerative conditions.

Area of Science:

• Neurology
• Neurosurgery
• Neuroscience

Background:

• Pharmacological treatments for major neurological diseases show limited efficacy.
• Novel surgical interventions are being developed to manage drug-induced side effects and pharmacoresistant symptoms.
• Deep brain stimulation (DBS) has proven effective for Parkinson's disease motor symptoms and levodopa side effects.

Purpose of the Study:

• To review the rationale, indications, and outcomes of neuromodulation for specific neurodegenerative conditions.
• To explore the application of DBS in treating secondary dystonia (PKAN), chorea (Huntington's disease), and cognitive decline (Alzheimer's dementia).
• To discuss emerging small molecule and gene-based neuromodulatory approaches.

Main Methods:

• Review of existing literature on neuromodulation techniques for neurodegenerative diseases.
• Analysis of DBS efficacy in Parkinson's disease and its expansion to other conditions.
• Discussion of non-DBS neuromodulatory strategies, including small molecule and gene-based therapies.

Main Results:

• DBS is a successful therapeutic option for Parkinson's disease motor symptoms and related side effects.
• The application of DBS is expanding to other neurodegenerative disorders like PKAN, Huntington's disease, and Alzheimer's dementia.
• Neuromodulation, including DBS and other approaches, represents an advanced care strategy for debilitating neurological conditions.

Conclusions:

• Invasive neuromodulation, particularly DBS, plays a crucial role in managing complex neurological diseases where pharmacological options are insufficient.
• Future research into pathophysiological mechanisms may lead to primary prevention strategies.
• Neuromodulation is increasingly vital for advanced patient care in neurodegenerative conditions.